Cowen Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Cowen Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform

Needham & Company Downgrades Adamas Pharmaceuticals (ADMS) to Hold

March 5, 2019 7:35 AM EST

Needham & Company analyst Serge Belanger downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) from Buy to Hold.

The analyst commented, "Gocovri ended 2018 with 4Q18 sales of $13.3MM (+25%Q/Q) via 5,730 fulfilled Rxs (+21%Q/Q) and was expected to double its market share to ~2% in... More

Mizuho Securities Downgrades Adamas Pharmaceuticals (ADMS) to Underperform

March 5, 2019 6:24 AM EST

Mizuho Securities analyst Irina Koffler downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) from Neutral to Underperform with a price target of $5.00 (from $11.00) after guidance was withdrawn.

we believe the launch is likely going even worse than we thoughtWe now model $58.5M in 2019... More